Former Gastro Health CEO Alejandro Fernandez takes top post at new company: 5 insights

Alejandro Fernandez is now CEO of New York City-based Navaderm Partners, a newly formed practice management company specializing in operating dermatology practices. 

Advertisement

 

Here’s what you should know:

1. BelHealth Investment Partners formed NavaDerm in partnership with Bronx, N.Y.-based Dermatology and Surgery Associates, Millburn (N.J.) Laser Center, Tenafly, N.J.-based Sharon Scherl Dermatology and New York City-based Spring Street Dermatology.

2. The platform will consist of 19 physicians in five New York and New Jersey locations.

3. The six founding dermatologists of the four acquired practices will remain in their respective practices and hold equity interest in the consolidated platform.

4. Mr. Fernandez is tasked with providing the leadership and direction for Navaderm as CEO.

5. Mr. Fernandez previously served as Miami-based Gastro Health’s CEO. He joined one of Gastro Health’s founding practices in 1997 and became the company’s CEO in 2011, a role he held until April 2018.

More articles on gastroenterology:
Gastro Health’s Alejandro Fernandez named to Miami Herald CEO Roundtable — 4 insights
Pomerene Gastroenterology Services adds Dr. Jonathan Hlivko — 3 insights
ModMed scoops Thomson Reuters exec to serve as COO, President

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.